Our research focuses on HPV vaccine initiation among low-income and minority groups in public healthcare settings. Our work to address racial/ethnic disparities in HPV vaccination rates in children and adolescents and in cervical cancer screenings in adult women has made us a world leader in HPV-related cancer prevention among minority communities. Presently we have two HPV vaccine studies funded by Merck MISP.
See all of our Pediatric Research programs.
Contact
PI: Elisha Wachman (Elisha.Wachman@bmc.org)
Investigators
Department of Pediatrics
General Clinical Research Unit (GCRU)
- Ridiane Denis, MD, RN
Research projects
- 2022-2028 Sponsor: Merck grant MISP # 61418 An exploratory open-label clinical trial evaluating the immunogenicity and safety of the 9vHPV 2-dose vaccine regimen in children aged 4–8 years.
- 2020-2024 Sponsor: Merck grant MISP #59402 An Open-Label Clinical Trial Evaluating the Immunogenicity of the 9vHPV Vaccination Regimen over 6 months Among Women Aged 16 to 45 years old, An Exploratory Immunogenicity Study ; NCT04206813